重大事件
即時報告
8-K
2026-06-18
MapLight Therapeutics 提交8-K報告 披露董事及高管人事變動
AI 繁中摘要
MapLight Therapeutics, Inc. 於2026年6月18日向美國證券交易委員會（SEC）提交了一份8-K即時報告，涵蓋Item 5.02項下關於董事或特定高管的離職、選舉、任命及相關薪酬安排的事項。報告期為同日。該公司為一間專注藥物製劑的製藥企業，總部設於加州紅木城。是次申報並未披露具體人事變動細節或金額，投資者應關注該公司後續可能公布的董事會或管理層調整，以及相關薪酬安排對公司管治及未來發展的潛在影響。完整文件已於SEC EDGAR系統存檔。
展開英文正文
EDGAR Filing Documents for 0001193125-26-276065 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-276065 Filing Date 2026-06-18 Accepted 2026-06-18 17:00:35 Documents 11 Period of Report 2026-06-18 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d227825d8k.htm iXBRL 8-K 23640 Complete submission text file 0001193125-26-276065.txt 138810 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA mplt-20260618.xsd EX-101.SCH 3187 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mplt-20260618_lab.xml EX-101.LAB 17977 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mplt-20260618_pre.xml EX-101.PRE 11263 14 EXTRACTED XBRL INSTANCE DOCUMENT d227825d8k_htm.xml XML 3648 Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-839-4360 MapLight Therapeutics, Inc. (Filer) CIK: 0001770069 (see all company filings) EIN.: 832163243 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-42914 | Film No.: 261103844 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)